Page 9 - GTM-2-4
P. 9

Global Translational Medicine





                                        EDITORIAL
                                        A message from the Editor-in-Chief, Prof. Lemin

                                        Zheng



                                                   †
                                        Lemin Zheng *
                                        The Institute of Cardiovascular Sciences, Peking University, Beijing, China




                                        The year 2023, which is the 2  year since Global Translational Medicine (GTM) was
                                                                nd
                                        launched, saw a steady growth of the journal, accompanied by several accomplishments
                                        that we are proud  to  share with our readers. The most encouraging achievement,
                                        unquestionably, is the inclusion of  GTM in the CAS databases. Such indexing
                                        accomplishment is a testament to the growing scientific recognition and citation
                                        impact of the journal, paving the way for inclusion in other indexing services, including
                                        PubMed, in the future.
                                          GTM also celebrates a surge in prominence in its field as more and more scientists
                                        are inducted to the editorial board, which plays a significant role in supporting
                                        the journal and devising plans for the strategic development of the journal. In
                                        addition, over the year 2023 we witnessed an increasing number of submissions to
                                        GTM, convincing evidence that the general interest in submitting to open-access
                                        journals in the field of translational medicine remains uneroded. GTM had a humble
                                        beginning in 2022, with a total submission count of only 38. However, this number
                                        has risen to more than 100 in 2023, accompanied by published papers which is twice
                                        the amount in 2022. Such success is not possible without the evaluative efforts of
            † Professor Lemin Zheng is   our peer reviewers from different countries, backgrounds, and expertise areas. We
            the Editor-in Chief of Global   are grateful for the contributions of the peer reviewers who directly help enhance
            Translational Medicine      the academic and scientific quality of GTM. A more robust peer-review practice also
            *Corresponding author:      signals that the article rejection rate will be increased so as to safeguard the journal’s
            Lemin Zheng                 quality as a whole.
            (zhengl@bjmu.edu.cn)
                                          We believe that 2024 is going to be an eventful and remarkable year for GTM.
            Citation: Zheng. L, 2023,
            A message from the Editor-in-Chief,   In particular, we plan to hold an academic conference in the name of the journal
            Prof. Lemin Zheng. Global Transl   in 2024. Thus, we are in the middle of seeking abstract submissions describing
            Med, 2(4): 2365.            transformative works from around the world. Aside from that, GTM is forming
            https://doi.org/10.36922/gtm.2365
                                        academic alliances with prestigious academic and government institutions
            Received: December 4, 2023   to expand our influence and invite high-quality research papers from these
            Published Online: December 29,
            2023                        institutions.
            Copyright: © 2023 Author(s).   We are grateful for having a strong editorial team for maintaining high academic
            This is an Open-Access article   quality for the journal as well as upholding professional standards. Our gratitude also
            distributed under the terms of the   goes to the in-house editors, who always stay committed to serving every author, for
            Creative Commons Attribution
            License, permitting distribution,
            and reproduction in any medium,
            provided the original work is
            properly cited.
            Publisher’s Note: AccScience
            Publishing remains neutral with
            regard to jurisdictional claims in
            published maps and institutional
            affiliations.


            Volume 2 Issue 4 (2023)                         1                        https://doi.org/10.36922/gtm.2365
   4   5   6   7   8   9   10   11   12   13   14